Information  X 
Enter a valid email address

Gresham House St PLC (GHS)

  Print      Mail a friend       Annual reports

Wednesday 15 May, 2019

Gresham House St PLC

Mello Trusts and Funds Conference

RNS Number : 0967Z
Gresham House Strategic PLC
15 May 2019
 

Gresham House Strategic plc

 

("GHS" or "the Company")

 

 

Mello Trusts and Funds conference

 

 

Gresham House Strategic plc (AIM: GHS) will be presenting at the Mello Trusts and Funds conference on Wednesday 15 May at 4.00 pm, at the Clayton Conference Centre, Chiswick, London.

 

The Company will also be hosting a stand at the event. Promotional materials provided at the event will be made available on the Company's website. The presentation will not contain any material new information.

 

More information about Mello's Trusts and Funds conference can be found at: https://melloevents.com/trusts-fund 

 

- Ends -

 

 

For further information contact:

 

Gresham House Strategic plc  

Graham Bird, Lead Fund Manager

 

 

+44 (0) 20 3757 5613

 

FinnCap - Nominated Adviser and Broker

Stuart Andrews

William Marle

 

 

+44 (0) 20 7220 0500

 

About Gresham House Strategic plc 

 

GHS invests primarily in UK and European smaller public companies, applying private equity techniques and due diligence alongside a value investment philosophy to construct a focused portfolio expected to be comprised of 10-15 companies.

 

The Strategic Public Equity mandate utilises the principles and practices of private equity to invest in influential stakes in UK smaller public and private companies which it believes to be undervalued. As such, the team has an engaged, active style of investing, working closely with management teams, to create shareholder value through strategic or operational initiatives, supporting a clear 3-5 year management plan to implement these initiatives.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCSFUSWIFUSELI

a d v e r t i s e m e n t